logo
Select company
Select metric
$ 0Net Income to Non-Controlling Interests
VS
Market
10
Sector
8
Industry
6
History
-
$ 3.28Close
$ 0.9 - $ 3.3 52-Week Range
Ticker Information

Ticker

ARMP

Company Name

ARMATA PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

ARMATA PHARMACEUTICALS INC - Net Income to Non-Controlling Interests Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ARMP - Net Inc. NCI Historical data
DateNet Income to Non-Controlling Interests
6/30/2025$ 0
3/31/2025$ 0
12/31/2024$ 0
9/30/2024$ 0
6/30/2024$ 0
3/31/2024$ 0
12/31/2023$ 0
9/30/2023$ 0
6/30/2023$ 0
3/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ARMATA PHARMACEUTICALS INC's latest trailing twelve months (TTM) Net Inc. NCI stands at $ 0.
  • Over the past 5 years, ARMATA PHARMACEUTICALS INC's average Net Inc. NCI has been $ 0.
  • The median Net Inc. NCI for ARMATA PHARMACEUTICALS INC during this period was $ 0
  • ARMATA PHARMACEUTICALS INC reached its highest Net Inc. NCI over the past 5 years at $ 0.
  • The lowest Net Inc. NCI recorded by ARMATA PHARMACEUTICALS INC in the same timeframe $ 0

ARMATA PHARMACEUTICALS INC's Net Inc. NCI vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Net Inc. NCI Benchmarks
CompanyNet Inc. NCI
CBUS : CIBUS INC $ -27.89MACOG : ALPHA COGNITION INC $ 0PYXS : PYXIS ONCOLOGY INC $ 0ORMP : ORAMED PHARMACEUTICALS INC $ 81KNTRB : NUTRIBAND INC $ 0PSTV : PLUS THERAPEUTICS INC $ 0DYAI : DYADIC INTERNATIONAL INC $ 0ALGS : ALIGOS THERAPEUTICS INC $ 0TCRX : TSCAN THERAPEUTICS INC $ 0IMDX : INSIGHT MOLECULAR DIAGNOSTICS INC $ 0

Definition of Net Income to Non-Controlling Interests

[Income Statement] The portion of income which is attributable to non-controlling interest shareholders; subtracted from [ConsolInc] in order to obtain [NetInc].

ARMP - Net Income to Non-Controlling Interests, Last 5 years

$ 0

Minimum

Sep 30, 2020

$ 0

Maximum

Sep 30, 2020

$ 0

Average

$ 0

Median

Net Inc. NCI Benchmark Analysis

The chart above depicts the distribution of Net Inc. NCI for companies in the Total Stock Market. The average Net Inc. NCI of the companies is $ 11.12M with a standard deviation of $ 136.5M.
The following table provides additional summary stats:
Net Inc. NCI in the Market:
filtered constituents4.26K
min$ -1.8B
max$ 2.94B
average$ 11.12M
median$ 0
std$ 136.5M